Rytis Masiliūnas: Atrial Fibrillation and Stroke Care Disparities Across the Baltic Region
Rytis Masiliūnas, Neurologist at Vilnius University Hospital Santaros Klinikos, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Acta Neurologica Scandinavica, adding:
”I’m pleased to share our original article, just published in Acta Neurologica Scandinavica, and developed in collaboration with colleagues from 23 of 26 stroke centers across Lithuania, Latvia, and Estonia.
We conducted a cross-country analysis of 897 ischemic stroke cases, prospectively recorded in the RES-Q registry during Q1 of 2022.
Our findings reveal notable regional differences in stroke care:
- The prevalence of stroke patients with atrial fibrillation (AF) was among the highest reported in literature, ranging from 36.2% in Lithuania to 43.0% in Estonia.
- Anticoagulant use at stroke onset among patients with known AF varied significantly: from 72.7% in Estonia to only 34.9% in Latvia.
- Latvia had significantly lower recanalization rates (IVT 21.1%, EVT 5.1%) and limited inpatient rehabilitation access (2.7% vs. 30.5% in Lithuania and 20.2% in Estonia)
- This comprehensive multicenter comparison of stroke care in the Baltic states highlights a high burden of AF and important disparities in recanalization therapy and post-stroke rehabilitation pathways.
- The authors would like to thank all stroke centers, physicians, nurses, CT technicians, coordinators, administrators, and civil servants for contributing to improving stroke care quality in the Baltic states!”
Title: Stroke Care Performance in the Baltic States: A Multicenter Registry-Based Observational Study
Authors: Rytis Masiliūnas, Edgaras Zaboras, Aurelija Daškevičiūtė, Kristaps Jurjāns, Janika Kõrv, Riina Vibo, Vaidas Matijošaitis, Antanas Vaitkus, Agnete Teivāne, Arta Grosmane, Evija Miglāne, Guntis Karelis, Dalius Jatužis, Vitalija Šumskienė, Katrin Gross-Paju, Katrin Sikk, Inga Samarüütel, Katrin Antsov, Saulius Taroza, Vaidotas Gudžiūnas, Paulius Puzinas, Erika Galvanauskaitė, Gintarė Paulėkienė, Robert Mikulik, Aleksandras Vilionskis

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering